Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

FDA approves new Covid boosters as cases rise around US

Moderna and Pfizer shots approved with vaccinations potentially beginning as soon as this week

The Guardian - US

FDA approves updated Moderna and Pfizer Covid boosters set to arrive soon as cases rise – latest

An updated Coronavirus booster that targets a new variant is expected to be made available in September

The Independent UK

New Covid boosters approved as CDC set to decide who should receive them amid rising cases

Health officials say that the Pfizer and Moderna shots likely to be available later this week

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

US approves updated COVID vaccines to rev up protection this fall

U.S. regulators have approved updated COVID-19 vaccines from Pfizer and Moderna, shots aimed at revving up protection this fall and winter

The Independent UK

New COVID vaccines get FDA approval

Vaccines for a fall immunization drive against COVID-19 just got the green light from the Food and Drug Administration. The agency says the vaccines can protect people, as hospitalizations tick up.

WEKU

What you should know about new COVID shots

Updated COVID-19 shots will be part of a trio of fall vaccines that doctors hope will help avoid another “tripledemic.”

Chicago Sun-Times

FDA greenlights new COVID-19 shots for this fall - Roll Call

The FDA approved reformulated COVID-19 vaccines from Pfizer and Moderna, but deferred an expected authorization for Novavax’s vaccine.

Roll Call

Read news from The Economist, FT, and more,
with one subscription

Updated COVID shots are coming. They're part of a trio of vaccines to block fall viruses

Updated COVID-19 shots are coming soon, part of a trio of fall vaccines that doctors hope will help avoid another “tripledemic."

The Independent UK

South Africa ‘held to ransom’ by big pharma, overcharged for COVID vaccines

J&J, Pfizer charged South Africa between 15 and 33 percent more for COVID vaccine doses, contracts reveal.

Al Jazeera

FDA's greenlighting of maternal RSV vaccine represents a major step forward in protecting young babies against the virus

With the Food and Drug Administration’s Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have a major new tool at its disposal to protect infants against the highly contagious virus.

The Conversation

Who should get the new RSV vaccines? Here's everything you need to know

There are now RSV vaccines approved for older adults and for pregnant people, and antibody shots (not vaccines) available for babies. What's the difference?

LiveScience

FDA approves RSV vaccine for moms-to-be to guard their newborns

U.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns

The Independent UK

Pfizer's RSV vaccine to protect babies gets greenlight from FDA

The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV.

WEKU

Covid booster jabs could go on sale privately in UK in 2024

Health officials reiterate support for private provision as lower age limit for NHS booster vaccines raised to 65

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Management consultants can make great CEOs—but they have to get their hands dirty first

Some 47 Fortune 500 CEOs have spent time as management consultants but first took more junior roles.

The Guardian - UK

A tsunami of AI misinformation will shape next year’s knife-edge elections

If you thought social media had a hand in getting Trump elected, watch what happens when you throw AI into the mix

WEKU

Coronavirus FAQ: Is it wiser to get a booster now or wait for the new fall booster?

Maybe it's not a full-blown summer surge but COVID numbers are ticking up. For those with concerns due to personal risk factors or the start of the school year, the booster question is top of mind.

The Guardian - UK

‘Endless possibilities’: the chemists changing molecules atom by atom

A new method called ‘skeletal editing’ offers a hugely simplified way to alter matter, paving the way for world-changing innovations in personalised medicine and sustainable plastics

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Are Pfizer (PFE) and AbbVie (ABBV) Good Value Buys for August?

The pharma industry is poised to witness long-term growth with the introduction of generic medicines and growing demand for personalized and targeted treatments. Hence, fundamentally strong pharma stock AbbVie (ABBV) might be worth buying. However, it might not be the right time to invest in Pfizer (PFE). Keep reading.

The Independent UK

Babies should get new drug that prevents RSV, CDC panel says

A panel of U.S. health advisers is recommending that babies get a new drug to protect them against a respiratory virus

Zenger

The Most Objective Evidence Shows No Indication That Covid Vaccines Save More Lives Than They Take

Medical journals describe all-cause mortality in randomized controlled trials (RCTs)

Zenger

FDA Violated Own Safety And Efficacy Standards In Approving Covid-19 Vaccines For Children

Evidence the FDA used for those decisions violates at least three safety and efficacy standards from earlier FDA publications

WEKU

Tornado damage to Pfizer factory highlights vulnerabilities of drug supply

A tornado that ripped through a Pfizer plant in Rocky Mount, N.C., raised worries about shortages of medicines used in hospitals. The drugs include commonly used painkillers and anesthetics.

Barchart

3 Sectors, 3 Unusually Active Put Options to Sell

The markets have been on fire the past couple of weeks. While yesterday’s interest hike took some steam out of the markets, these three stocks and their options are unusually active and worthy of consideration.

Barchart

Is the Rally Getting Long in the Tooth? Try These Bear Call Spread Trades

Traders should have a bearish outlook on the stock and ideally look to enter when the stock has a high implied volatility rank.

1 … 21 22 23 24

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.